Gold and Silver Retreat Comex Precious Metals Settle Lower Amid Market Pressures Microsoft Appoints New Responsible Tech Lead Amid Tension Between AI Speed and Trustworthy Development Humana Shares Decline as Medicare Advantage Rate Update Disappoints Market Expectations Micron Technologys Path to a TrillionDollar Valuation An Analysis Broadening Inflation Pressures Beyond Iran and Oil Consumers Face Reacceleration in Multiple Categories Kazatomprom Reports 17 Production Surge in Q3 Amid Nuclear Energy Momentum BCSF Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Lincoln National Corporation LNC Q1 2026 Earnings BottomLine Beat Amidst Strategic Discipline RRR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 377 MSIF Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline VGZ Q1 2026 Earnings Negative EPS Reflects Development Stage Stock Rises on Project Milestones Brookfield Renewable Partners Q1 2026 Earnings Widely Missed EPS Estimates as Operating Challenges Persist Enact Holdings ACT Slips 122 as Housing Sector Headwinds Persist Braze Inc BRZE Slides 559 as Selling Pressure Intensifies Testing Key Support Level Cooper Companies COO Edges Lower as Shares Test Key Support Levels Osisko Development Corp ODV Gains 26 as Stock Approaches Key Resistance at 290 Phoenix New Media FENG Holds Steady at 168 as Consolidation Continues Near Support Applied Digital APLD Surges to AllTime High as AI Lease Revenues Reach 73 Billion Gogoro Inc Q1 2026 Earnings Wider Net Loss Reported Amidst Operational Adjustments Artelo Biosciences ARTL Slides 105 as Shares Test Key Support Levels Titan Mining Corporation TII Q1 2026 Earnings Unexpected Profit Beats Estimate as Shares Slide PAPL Q3 2025 Earnings Narrowed Loss Beats Estimates by 51 STERIS plc STE Q1 2026 Earnings EPS Falls Short Amid Mixed Operating Conditions FIS Q1 2026 Earnings EPS Surpasses Estimates by 46 Despite Minor Stock Dip VRM Q3 2025 Earnings Loss Per Share Deepens Stock Declines Amid Missing Revenue Disclosures ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress MWA Q1 2026 Earnings EPS Surpasses Estimates by 65 Amid Strong Operational Performance